Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Rs 92 Cr Drug Factory Busted in Bhopal: DRI Arrests 7, Exposes International Mephedrone Syndicate

Drugs and Cosmetics Act Set for Fresh Decriminalization Under Jan Vishwas Bill 2025

Susmita Roy21 Aug 2025 7:16 PM IST

New Delhi: The Drugs and Cosmetics Act, 1940, key legislation governing India's pharmaceutical sector, is set for further decriminalization under the...

CDSCO Panel Approves Emcure's Phase III Clinical Trial of Semaglutide, Mandates Govt Trial Sites

Susmita Roy21 Aug 2025 6:53 PM IST

New Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Susmita Roy20 Aug 2025 4:20 PM IST

New Delhi: Following a thorough discussion on the proposed Phase III clinical trial protocol for roflumilast cream, the Subject Expert Committee (SEC)...

Illegal Alprazolam Unit Busted in Andhra, 8 Arrested, Drugs Worth Rs 24 Crore Seized

Susmita Roy20 Aug 2025 3:58 PM IST

New Delhi: In a major crackdown on the illegal drug trade, the Directorate of Revenue Intelligence (DRI) has discovered a clandestine manufacturing...

Sun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns

Susmita Roy19 Aug 2025 3:11 PM IST

New Delhi: Expressing doubts over the clinical utility of administering such a small dose of Glimepiride once daily, especially considering over the...

Submit BE Raw Data, Interaction Study on Dapagliflozin-Rosuvastatin FDC: Expert Panel Tells Pure and Cure

Susmita Roy19 Aug 2025 3:02 PM IST

New Delhi: In line with the proposal presented by Pure and Cure Healthcare for the Dapagliflozin plus Rosuvastatin film-coated tablet, the Subject...

Bayer Gadoquatrane new drug application accepted for review by USFDA

Bayer Gets CDSCO Committee Nod to Manufacture, Market Darolutamide 300 mg for mHSPC, PMS Study Mandated

Susmita Roy18 Aug 2025 2:00 PM IST

New Delhi: Bayer Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

AiMeD Flags Risks in GST Overhaul For Medical Devices, Seeks Balanced 5%-12% Tax Structure

Imported Devices Face 7.5-10% Duty, Domestic Devices GST at 12%, Govt Clarifies

Susmita Roy17 Aug 2025 4:00 PM IST

New Delhi: While imported medical devices attract a basic customs duty of 7.5-10% along with a 5% health cess, domestically manufactured medical...

Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML

Susmita Roy17 Aug 2025 4:00 PM IST

New Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...

Sun Pharma Gets CDSCO Panel Nod for Active PMS of Fexuprazan Hydrochloride Tablets

Susmita Roy15 Aug 2025 2:31 PM IST

New Delhi: Sun Pharma Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

Chemists' Body Warns of 55% Rise in Drug Abuse, Calls for Ban on 10-Minute Prescription Drug Delivery

Susmita Roy15 Aug 2025 11:30 AM IST

New Delhi: Speaking up against a worrying circumstance, the All India Organisation of Chemists and Druggists (AIOCD), representing over 12.40 lakh...

Setback to Torrent: CDSCO Panel Rejects Phase III Waiver Plea for Prucalopride Over Safety Data Gaps

Susmita Roy14 Aug 2025 9:28 PM IST

New Delhi: Citing that Torrent Pharmaceuticals has not presented adequate safety data on the synergistic effect of added excipients (propylene glycol,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok